Prostate cancer is a malignancy of one of the major male sex glands, in which cells of the prostate become abnormal and start to grow uncontrollably, forming tumors.
Quick test for prostate cancer – A new 3-minute test could help in diagnosing prostate cancer, the most common cancer in men in the UK, according to scientists. – A new 3-minute test could help in diagnosing prostate cancer, the most common cancer in men in the UK, according to scientists. Researchers have developed the test by using light energy to measure the level of citrate in fluid samples from the prostate gland.
City-dwellers have higher risk of late-stage cancer than rural residents – People who live in urban areas are more likely to develop late-stage cancer than those who live in suburban and rural areas. That is the conclusion of a new study published in the June 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
Genetic marker may predict early onset of prostate cancer – Fox Chase Cancer Center researchers have identified a genetic marker that is associated with an earlier onset of prostate cancer in Caucasian men who have a family history of prostate cancer. If the data are confirmed, the marker may help clinicians personalize prostate cancer screening.
Home-based Diet and Exercise Intervention Can Improve Physical Function in Older Cancer Survivors. – A home-based program aimed at improving exercise and diet can lead to meaningful improvements in physical function among older long-term cancer survivors, according to the results of a study led by researchers from Duke University Medical Center and The University of Texas M.D. Anderson Cancer Center.
Surgery improves survival for prostate cancer patients younger than 50 – For men younger than 50 with prostate cancer, undergoing a radical prostatectomy can greatly increase their chances for long-term survival, according to a new study from Henry Ford Hospital.
Prostate cancer immunotherapy significantly prolongs survival in men with advanced prostate cancer. Phase 3 IMPACT trial results to be presented during late-breaking session at AUA Annual Scientific Meeting. – Sipuleucel-T (Provenge), an experimental immunotherapy improved survival in men with metastatic disease, according to new results to be presented April 28 at the American Urological Association (AUA) Annual Scientific Meeting in Chicago.
AUA counters mainstream recommendations with new best practice statement on PSA testing. New guidance stresses that PSA testing should be individualized, men should get baseline reading at age 40. – The American Urological Association (AUA) issued new clinical guidance ? which directly contrasts recent recommendations issued by other major groups ? about prostate cancer screening, asserting that the prostate-specific antigen (PSA) test should be offered to well-informed, men aged 40 years or older who have a life expectancy of at least 10 years.
Statins may exert influence on prostate cancer growth by reducing inflammation. – Cholesterol lowering drugs called statins may reduce inflammation in prostate tumors, possibly hindering cancer growth, according to a study led by investigators in the Duke Prostate Center.
American Cancer Society awards 143 research grants to investigators at 83 institutions nationwide. Grants total more than $51 million in the second of two cycles for 2009. – The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 143 national research and training grants totaling more than $51 million in the second of two grant cycles for 2009. The grants go into effect beginning July 1, 2009.
University of Leicester team examine potential of new nano technology to pave way for development of a combined diagnosis/therapeutic strategy for cancer. – A multi-disciplinary team of scientists from the University of Leicester could be potentially paving the way for the development of a powerful new strategy for both the early diagnosis and treatment of prostate cancer.
